Sputnik Light gets emergency use nod in Philippines
Manila: The Philippines has approved the emergency use of Russia's Sputnik Light COVID-19 vaccine, the country's vaccine procurement chief said on Monday, making it among the first countries in Asia to approve the single-dose vaccine.
The approval by the Philippines' food and drug agency will allow the country to follow up its order for 10 million doses, Carlito Galvez, a retired general who handles the government's vaccine procurement, told a news conference.
The government expects vaccine manufacturers to increase deliveries in September and October, Galvez said.
Mongolia and Kazakhstan have approved Sputnik Light, developed by Russia's Gamaleya Institute.
Sputnik Light is ninth COVID-19 vaccine approved by the Philippines, along with vaccines from Pfizer, Moderna, Johnson & Johnson and China's Sinovac and Sinopharm.
Read also: RDIF proposes Pfizer conduct joint trials with Sputnik Light as booster shot
Philippine authorities have said the vaccine rollout is key to the recovery of the Southeast Asian country's economy. The Philippines was one of the fastest growing economies in Asia before the pandemic, but contracted by a record 9.6% in 2020.
The Philippines has so far fully vaccinated 17.26 million people, leaving much of its 110 million population vulnerable to the highly contagious Delta variant.
Read also: Wockhardt, RDIF collaborate for producing Sputnik V, Sputnik Light
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.